FDA Inspection 1004536 - Boehringer Ingelheim Pharmaceuticals, Inc. - February 28, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Boehringer Ingelheim Pharmaceuticals, Inc., with an inspection on February 28, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Boehringer Ingelheim Pharmaceuticals, Inc.
Inspection Date: February 28, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 348dac8e-c7ba-4f7a-aacc-cec40017cc2a

Violation Codes1

21 CFR 312.50

Full citation text and observation details available on the Dashboard.